Compare Liquidia Corporation Common Stock (LQDA) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Tilray Brands Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.7 (market cap $3.04B), while Tilray Brands Inc trades at $3.24 (market cap $463.31M). The key difference: Liquidia Corporation Common Stock is far larger — about 6.6× Tilray Brands Inc's market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Tilray Brands Inc for 31 Days on average.
| LQDA | TLRY | |
|---|---|---|
Market Cap | $3.04B | $463.31M |
Volume | 21,111,778 | 4,627,093 |
Sector | Health | Health |
52-Week High | $91.03 | $16.80 |
52-Week Low | $22.02 | $3.14 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $2.94B | $617.23M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $3.17, down 3.06% on the day and near its 52-week low, reflecting persistent bearish sentiment. The stock exhibits weak fundamentals with a net income margin of -17.05% and negative cash flow from operations of -$94.60M in 2025. Recent earnings have consistently missed expectations, and technical indicators signal a bearish trend. However, the company maintains a diversified portfolio in cannabis, beverages, and wellness, with revenue growth projected to $963M in 2026.
The outlook remains challenging due to ongoing losses and high debt, but a low P/S ratio of 0.39 and analyst consensus price target of $65.01 suggest potential long-term upside if profitability improves. Key risks include regulatory uncertainty, competitive pressures, and reliance on financing activities to sustain operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
